You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海爾生物(688139.SH):子公司簽訂土地使用權出讓合同 推進產業園項目
格隆匯 06-16 15:55

格隆匯6月16日丨海爾生物(688139.SH)公吿,公司於2021年3月16日召開第一屆董事會第二十六次會議審議通過了《關於投資建設產業園的議案》,同意公司與青島高新技術產業開發區管理委員會合作,以公司全資子公司青島海特生物醫療有限公司(“項目公司”)作為項目實施主體,在青島市高新區建設海爾生物安全科創產業園(“產業園”),產業園預計總投資金額不超過人民幣5億元。

2021年5月26日,項目公司通過招拍掛的方式取得位於高新區華東路以東、正陽路以北、規劃東17號線以南、規劃東4號線以西地塊的土地使用權。2021年6月15日,項目公司與青島市自然資源和規劃局就該等土地使用權的出讓事項簽訂了《國有建設用地使用權出讓合同》。

本次土地使用權的取得有利於推進公司的產業園項目進一步落地實施,有利於公司提升生物低温存儲、生物培養、生物離心製備、樣本自動化、生物低温轉運等生物安全場景方案的研發、生產能力,保障用户體驗持續迭代,對公司完善產業佈局規劃、夯實未來發展基礎具有重大意義。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account